|
Research Management and Support
|
RMS ES 2017
|
$326,124,631
|
$21,000
|
N/A
|
National Institutes of Health
|
|
Training Program in Cancer Biology
|
5T32CA078207-19
|
$554,252
|
|
AARONSON, STUART
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Center for Multiple Myeloma Nanotherapy
|
5U54CA199092-04
|
$2,184,301
|
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
5R01CA198915-04
|
$568,727
|
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-04S1
|
$1,393,520
|
$83,611
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Discovery and Characterization of Mutations in Breast and Ovarian Cancers
|
5R50CA211280-03
|
$215,047
|
|
ADAMSON, AARON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-04
|
$400,000
|
$80,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-04
|
$22,547,116
|
$1,352,827
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Mutagenesis and migration in glioblastoma cells
|
1R21CA220111-01A1
|
$179,240
|
|
AHN, EUN HYUN
|
UNIVERSITY OF WASHINGTON
|
|
Cancer Prevention and Control Health Disparities Training Program
|
5T32CA078447-18
|
$161,530
|
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
p63 as a novel factor promoting pregnancy-induced HER2-positive breast cancer
|
5K22CA190653-03
|
$157,743
|
|
ALEXANDROVA, EVGUENIA
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance
|
5F30CA220847-02
|
$49,524
|
|
ALI, MOIEZ
|
DUKE UNIVERSITY
|
|
Profiling signaling activity and gene expression in single, pancreatic adenocarcinoma cells using CE-RNA-Seq
|
1R01CA224763-01A1
|
$575,272
|
|
ALLBRITTON, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Single-Cell Measurement of Lipid Signaling in Colorectal Cancer
|
5R01CA177993-05
|
$575,397
|
|
ALLBRITTON, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
5R01CA183811-05
|
$435,560
|
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
Novel Molecular Therapies of Prostate Cancer
|
5P01CA140043-09
|
$1,222,825
|
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Bitter Melon Component and Colon Cancer Prevention
|
5R01CA190291-05
|
$544,710
|
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
RIP140 as a mediator of Estrogen Receptor action in tumor associated macrophages
|
5F31CA220978-02
|
$35,725
|
|
ANDREANO, KAITLYN
|
DUKE UNIVERSITY
|
|
Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients
|
5R01CA201124-03
|
$259,646
|
|
ANTONIA, SCOTT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
A Novel Values-based Intervention to Increase Endocrine Therapy Adherence among Breast Cancer Survivors
|
1R21CA218723-01A1
|
$207,450
|
|
ARCH, JOANNA
|
UNIVERSITY OF COLORADO
|
|
Reversing Cellular immortality in cancer
|
5R35CA197563-04
|
$962,915
|
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Postdoctoral Training Program in Cancer Survivorship
|
5R25CA122061-11
|
$236,400
|
|
AVIS, NANCY
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Risk-stratification of Prostate Cancers via Field Carcinogenesis Nanocytology
|
5R01CA200064-04
|
$628,861
|
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
(PQC3) Ethnicity-determined immune response and DCIS outcome
|
5R01CA194600-04
|
$179,518
|
|
BADVE, SUNIL
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
University of Washington/Fred Hutch Center for AIDS Research
|
2P30AI027757-31
|
$508,801
|
|
BAETEN, JARED
|
UNIVERSITY OF WASHINGTON
|
|
Puerto Rico NCI Community Oncology Research Program Minority/Underserved
|
5UG1CA189862-05
|
$717,072
|
|
BAEZ- DIAZ, LUIS
|
COMPREHENSIVE CANCER CENTER/ UNIV/PR
|
|
Bay Area Tumor Institute NCORP
|
5UG1CA189817-05
|
$826,500
|
|
BAILEY, LISA
|
BAY AREA TUMOR INSTITUTE
|
|
The DNA adductome of lung carcinogenesis
|
1R01CA220376-01A1
|
$348,000
|
|
BALBO, SILVIA
|
UNIVERSITY OF MINNESOTA
|
|
The role of The Xenopus Nonclassical MHC class I molecule XNC10 in Tumor Immunity
|
5F31CA192664-04
|
$42,497
|
|
BANACH, MAUREEN
|
UNIVERSITY OF ROCHESTER
|
|
Oncogenic Ras-induced macropinocytosis: A new paradigm for metabolic adaptation
|
5R35CA210263-03
|
$968,501
|
|
BAR-SAGI, DAFNA
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
A-to-I microRNA Editing and Melanoma Metastasis
|
1R21CA219958-01A1
|
$208,800
|
|
BARELI, MENASHE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Early detection of ovarian cancer by serum marker and targeted ultrasound imaging
|
5R01CA210370-03
|
$356,233
|
|
BARUA, ANIMESH
|
RUSH UNIVERSITY MEDICAL CENTER
|
|
Determining the Epigenetic Mechanisms Driving Tissue Factor (F3) Upregulation and its Role in Metastatic Osteosarcoma
|
5F31CA213965-02
|
$44,524
|
|
BAYLES, IAN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Iowa-Wide Oncology Research Coalition (I-WORC)
|
5UG1CA189816-05
|
$1,177,581
|
|
BEHRENS, ROBERT
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
Linking Oncogenic Signaling to Tumor Metabolism
|
5R00CA194192-04
|
$230,670
|
|
BEN-SAHRA, ISSAM
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
A high efficiency imager for real-time lung cancer monitoring during radiotherapy
|
5R01CA188446-05
|
$765,486
|
|
BERBECO, ROSS
|
DANA-FARBER CANCER INST
|
|
Hawaii Minority/Underserved NCORP
|
5UG1CA189804-05
|
$1,290,544
|
|
BERENBERG, JEFFREY
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Inter-regulatory function of immune-modulation and angiogenesis in cancer
|
5R01CA201537-03
|
$362,569
|
|
BERGERS, GABRIELE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
An assessment of whether aspirin and/or vitamin D improves breast cancer outcomes in Black women and the modifying effect of genetic variants
|
5K01CA212056-02
|
$133,775
|
|
BETHEA, TRACI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Ubiquilin1 regulates EMT and metastasis of human lung adenocarcinoma
|
5R01CA193220-04
|
$352,275
|
|
BEVERLY, LEVI
|
UNIVERSITY OF LOUISVILLE
|
|
Translational Molecular and Cellular Imaging Technologies for Prostate Tumor Pathology
|
5R33CA196458-03
|
$362,020
|
|
BHARGAVA, ROHIT
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
Combating Resistance to Antiangiogenic Therapy in Renal Cell Carcinoma
|
5R01CA196996-04
|
$398,025
|
|
BHATT, RUPAL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Oncolytic Polovirus, Immunotoxin, and Checkpoint Inhibitor Therapy of Gliomas
|
5R35CA197264-04
|
$912,796
|
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
Definition of the Microenvironment in Breast Cancer
|
5R01CA064786-22
|
$491,681
|
|
BISSELL, MINA
|
UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
|
|
Development of 5hmC and 5mC biomarkers in cell-free circulating DNA for sensitive colon cancer detection and prognosis
|
5U01CA217078-02
|
$597,821
|
|
BISSONNETTE, BRUCE
|
UNIVERSITY OF CHICAGO
|
|
SWOG NCORP Research Base
|
5UG1CA189974-05
|
$4,973,785
|
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Material Hardship as a Targetable Measure of Poverty in Pediatric Cancer
|
5K07CA211847-03
|
$133,475
|
|
BONA, KIRA
|
DANA-FARBER CANCER INST
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$356,352
|
$7,127
|
Bottaro, Donald
|
CCR (NCI)
|
|
MSKCC -Cornell Center for Translation of Cancer Nanomedicines.
|
5U54CA199081-04
|
$1,595,317
|
|
BRADBURY, MICHELLE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Expanding the Reach of a Validated Smoking-Cessation Intervention: A Spanish-language RCT
|
5R01CA199143-03
|
$568,985
|
|
BRANDON, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
Total relevant funding to Wilm's Tumor for this search: $5,416,517
|